Toulouse University Hospital
Clinical Trials
761
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (539 trials with phase data)• Click on a phase to view related trials
How do Patients With Amnesia Acquire New Knowledge?
- Conditions
- AmnesiaMemory Disorder
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 150
- Registration Number
- NCT07191197
- Locations
- 🇫🇷
University Hospital of Caen, Caen, France
🇫🇷University Hospital of Toulouse, Toulouse, France
AI-based Progression and Medication Response Prediction Study in Parkinson's Disease
- Conditions
- PARKINSON DISEASE (Disorder)
- First Posted Date
- 2025-09-24
- Last Posted Date
- 2025-09-24
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 100
- Registration Number
- NCT07189468
- Locations
- 🇫🇷
University Hospital of Toulouse, Toulouse, France
🇩🇪Technische Universität Dresden, Dresden, Germany
🇪🇸Hospital Ruber Internacional, Madrid, Spain
Evaluation of the Quality of Life and Gynecological Follow-up of Patients Treated for Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome
- Conditions
- Mrkh Syndrome
- First Posted Date
- 2025-09-22
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 102
- Registration Number
- NCT07186764
- Locations
- 🇫🇷
Service d'Endocrino-gynéco-pédiatrie, Hôpital des Enfants, 330 Avenue de Grande Bretagne, Toulouse, France
Assessment of Structural Brain Changes Related to Anoxic Coma Using High-field and Very Low Field Mobile MRI
- Conditions
- Anoxic ComaCardiac Arrest (CA)Anoxia-Ischemia, BrainComa
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 60
- Registration Number
- NCT07177755
- Locations
- 🇫🇷
CHU de Toulouse, Toulouse, France
Brain Areas of Cognitive Functions: a Study in Awake Surgery
- Conditions
- Cerebral Tumor
- First Posted Date
- 2025-09-12
- Last Posted Date
- 2025-09-12
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 120
- Registration Number
- NCT07170436
- Locations
- 🇫🇷
Service de Neurochirurgie, Hôpital Pierre Paul Riquet, Place du Docteur Baylac, Toulouse, Oui, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 152
- Next
News
Lixisenatide Shows Promise in Slowing Parkinson's Disease Progression in Phase 2 Trial
A Phase 2 trial of Sanofi's lixisenatide demonstrated the GLP-1 agonist's potential to halt motor symptom progression in Parkinson's disease patients over 12 months.